Compare GraniteShares 2x Long COIN Daily ETF (CONL) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GraniteShares 2x Long COIN Daily ETF vs Quest Diagnostics Inc — how do they compare? GraniteShares 2x Long COIN Daily ETF trades at $5.26 (market cap $510.01M), while Quest Diagnostics Inc trades at $230.97 (market cap $25.48B). The key difference: Quest Diagnostics Inc is far larger — about 50× GraniteShares 2x Long COIN Daily ETF's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while GraniteShares 2x Long COIN Daily ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold GraniteShares 2x Long COIN Daily ETF for 15 Days and Quest Diagnostics Inc for 56 Days on average.
| CONL | DGX | |
|---|---|---|
Market Cap | $510.01M | $25.48B |
Volume | 21,041,836 | 941,866 |
Sector | Leveraged / Inverse | Health |
52-Week High | $41.19 | $247.45 |
52-Week Low | $3.93 | $173.49 |
Typical Hold Time | 15 Days | 56 Days |
Enterprise Value | — | $31.23B |
Dividend Yield | — | 1.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CONL, the GraniteShares 2x Long COIN Daily ETF, trades at $4.85, down 7.27% with bearish technical signals from moving averages. The ETF provides leveraged exposure to Coinbase stock, experiencing significant volatility as highlighted in recent financial media coverage. Key oscillators show oversold conditions with RSI readings below 22, suggesting potential for near-term bounce.
The outlook remains challenging given the leveraged structure's sensitivity to Coinbase volatility. Investment opportunity exists for tactical traders betting on Coinbase recovery, but risks include amplified losses during downtrends and the structural decay inherent in daily reset leveraged products.
Quest Diagnostics (DGX) trades at $230.81, up 1.68% with strong year-to-date performance driven by organic growth and advanced diagnostics adoption. The company has consistently beaten earnings expectations in recent quarters with Q2 2026 EPS of $3.12 exceeding estimates. Technical indicators show a bearish bias while fundamentals remain solid with 9.19% net margin and 14.35% ROE. Recent developments include a partnership with Apple Health app and positive clinical study results.
DGX presents a mixed outlook with strong fundamental performance offset by technical weakness and regulatory headwinds. The 38% upside to consensus price target of $250 offers potential, but Medicare reimbursement cuts and bearish technical signals warrant caution. Growth in consumer testing and strategic partnerships provide catalysts, though execution risks and debt levels require monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GraniteShares 2x Long COIN Daily ETF
CONL is a leveraged ETF that seeks to provide two times (2x) the daily performance of Coinbase Global (COIN) stock. It is designed for investors seeking magnified short-term exposure to the price movements of Coinbase.
Read more on CONL →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
